FIELD: medicine.
SUBSTANCE: DNA is extracted from the scrapes from the nasal cavity mucosa in 5% solution of serum bovine albumin. Real time PCR is performed using external and internal primers.
EFFECT: improved efficiency of leprosy causative agent identification.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING EFFICIENCY OF THE TREATMENT OF LEPROSY WITH POLYMERASE CHAIN REACTION | 2017 |
|
RU2688156C2 |
| METHOD OF LEPROSY DIAGNOSIS | 1996 |
|
RU2124730C1 |
| METHOD FOR PREDICTION OF RECURRENCE RISK IN LEPROSY PATIENTS | 2008 |
|
RU2373529C1 |
| METHOD FOR EVALUATING THE EFFECTIVENESS OF LEPROSY THERAPY USING POLYMERASE CHAIN REACTION FOR AMPLIFICATION OF SPECIES-SPECIFIC SECTIONS OF THE LEPROSY, HUMAN OR MOUSE GENOMES | 2021 |
|
RU2759232C1 |
| METHOD FOR INCREASE OF REAL TIME POLYMERASE CHAIN REACTION SENSITIVITY IN DETECTION OF PATHOGENIC BACTERIA DNA | 2016 |
|
RU2636458C1 |
| METHOD OF IDENTIFICATION OF MYCOBACTERIUM LEPRAE IN PATIENTS WITH DISEASE REGRESSION | 1997 |
|
RU2137137C1 |
| METHOD OF ESTIMATION OF LEPROSY RELAPSE RISK GROUP | 1993 |
|
RU2082979C1 |
| METHOD FOR DIAGNOSING LEPROSIS | 2000 |
|
RU2171689C1 |
| METHOD FOR Mycobacterium leprae ANTIBODY TEST | 2012 |
|
RU2501022C2 |
| METHOD FOR Mycobacterium leprae ANTIBODY TEST | 2012 |
|
RU2500423C1 |
